ID DBF4B_HUMAN Reviewed; 615 AA. AC Q8NFT6; D3DX56; Q8TEX0; Q96B19; Q9H912; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2002, sequence version 1. DT 24-JAN-2024, entry version 148. DE RecName: Full=Protein DBF4 homolog B; DE AltName: Full=Activator of S phase kinase-like protein 1; DE Short=ASK-like protein 1; DE AltName: Full=Chiffon homolog B; DE AltName: Full=Dbf4-related factor 1; GN Name=DBF4B; Synonyms=ASKL1, DRF1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, RP PHOSPHORYLATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INTERACTION RP WITH CDC7. RX PubMed=12065429; DOI=10.1093/emboj/cdf290; RA Montagnoli A., Bosotti R., Villa F., Rialland M., Brotherton D., RA Mercurio C., Berthelsen J., Santocanale C.; RT "Drf1, a novel regulatory subunit for human Cdc7 kinase."; RL EMBO J. 21:3171-3181(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). RA Shannon M.; RL Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND INTERACTION WITH RP CDC7. RX PubMed=15668232; DOI=10.1074/jbc.m411653200; RA Yoshizawa-Sugata N., Ishii A., Taniyama C., Matsui E., Arai K., Masai H.; RT "A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for RT efficient progression of S and M phases."; RL J. Biol. Chem. 280:13062-13070(2005). RN [7] RP FUNCTION, AND INTERACTION WITH CDC7. RX PubMed=17062569; DOI=10.1074/jbc.m604457200; RA Tenca P., Brotherton D., Montagnoli A., Rainoldi S., Albanese C., RA Santocanale C.; RT "Cdc7 is an active kinase in human cancer cells undergoing replication RT stress."; RL J. Biol. Chem. 282:208-215(2007). CC -!- FUNCTION: Regulatory subunit for CDC7 which activates its kinase CC activity thereby playing a central role in DNA replication and cell CC proliferation. Required for progression of S and M phases. The complex CC CDC7-DBF4B selectively phosphorylates MCM2 subunit at 'Ser-40' and then CC is involved in regulating the initiation of DNA replication during cell CC cycle. {ECO:0000269|PubMed:12065429, ECO:0000269|PubMed:15668232, CC ECO:0000269|PubMed:17062569}. CC -!- SUBUNIT: Forms a complex with CDC7. Note that CDC7 forms distinct CC complex either with DBF4/DBF4A or DBF4B. Such complexes are stable upon CC replication stress. CC -!- INTERACTION: CC Q8NFT6; P25791: LMO2; NbExp=3; IntAct=EBI-749662, EBI-739696; CC Q8NFT6-2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-12205861, EBI-3867333; CC Q8NFT6-2; P55040: GEM; NbExp=3; IntAct=EBI-12205861, EBI-744104; CC Q8NFT6-2; Q96MH2: HEXIM2; NbExp=3; IntAct=EBI-12205861, EBI-5460660; CC Q8NFT6-2; Q99750: MDFI; NbExp=3; IntAct=EBI-12205861, EBI-724076; CC Q8NFT6-2; Q92824-2: PCSK5; NbExp=3; IntAct=EBI-12205861, EBI-11956269; CC Q8NFT6-2; Q9HAT0: ROPN1; NbExp=6; IntAct=EBI-12205861, EBI-1378139; CC Q8NFT6-2; Q96ES7: SGF29; NbExp=3; IntAct=EBI-12205861, EBI-743117; CC Q8NFT6-2; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-12205861, EBI-5235340; CC Q8NFT6-2; P14373: TRIM27; NbExp=3; IntAct=EBI-12205861, EBI-719493; CC Q8NFT6-2; Q8N720: ZNF655; NbExp=3; IntAct=EBI-12205861, EBI-625509; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12065429, CC ECO:0000269|PubMed:15668232}. Note=Predominantly found in soluble CC fraction but not in the chromatin-bound fraction. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q8NFT6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8NFT6-2; Sequence=VSP_031018, VSP_031019; CC Name=3; CC IsoId=Q8NFT6-3; Sequence=VSP_031014, VSP_031017; CC Name=4; CC IsoId=Q8NFT6-4; Sequence=VSP_031015, VSP_031016; CC -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in testis. CC {ECO:0000269|PubMed:12065429}. CC -!- DEVELOPMENTAL STAGE: Increases as cells enter in S phase through G2/M CC phase. The protein has a short half-life (at protein level). CC {ECO:0000269|PubMed:12065429, ECO:0000269|PubMed:15668232}. CC -!- PTM: Phosphorylated. {ECO:0000269|PubMed:12065429}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF448801; AAM73808.1; -; mRNA. DR EMBL; AF465820; AAL75985.1; -; mRNA. DR EMBL; AK023149; BAB14431.1; -; mRNA. DR EMBL; CH471178; EAW51581.1; -; Genomic_DNA. DR EMBL; CH471178; EAW51584.1; -; Genomic_DNA. DR EMBL; CH471178; EAW51587.1; -; Genomic_DNA. DR EMBL; CH471178; EAW51582.1; -; Genomic_DNA. DR EMBL; CH471178; EAW51586.1; -; Genomic_DNA. DR EMBL; BC016158; AAH16158.1; -; mRNA. DR CCDS; CCDS11485.1; -. [Q8NFT6-1] DR CCDS; CCDS45706.2; -. [Q8NFT6-2] DR RefSeq; NP_079380.2; NM_025104.3. [Q8NFT6-2] DR RefSeq; NP_663696.1; NM_145663.2. [Q8NFT6-1] DR RefSeq; XP_006722165.1; XM_006722102.3. DR RefSeq; XP_011523583.1; XM_011525281.2. [Q8NFT6-3] DR AlphaFoldDB; Q8NFT6; -. DR SMR; Q8NFT6; -. DR BioGRID; 123157; 35. DR IntAct; Q8NFT6; 29. DR MINT; Q8NFT6; -. DR STRING; 9606.ENSP00000323663; -. DR GlyGen; Q8NFT6; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q8NFT6; -. DR PhosphoSitePlus; Q8NFT6; -. DR BioMuta; DBF4B; -. DR DMDM; 74715595; -. DR EPD; Q8NFT6; -. DR jPOST; Q8NFT6; -. DR MassIVE; Q8NFT6; -. DR MaxQB; Q8NFT6; -. DR PaxDb; 9606-ENSP00000323663; -. DR PeptideAtlas; Q8NFT6; -. DR ProteomicsDB; 73350; -. [Q8NFT6-1] DR ProteomicsDB; 73351; -. [Q8NFT6-2] DR ProteomicsDB; 73352; -. [Q8NFT6-3] DR ProteomicsDB; 73353; -. [Q8NFT6-4] DR Antibodypedia; 29863; 160 antibodies from 22 providers. DR DNASU; 80174; -. DR Ensembl; ENST00000315005.8; ENSP00000323663.3; ENSG00000161692.18. [Q8NFT6-1] DR Ensembl; ENST00000393547.6; ENSP00000377178.2; ENSG00000161692.18. [Q8NFT6-2] DR GeneID; 80174; -. DR KEGG; hsa:80174; -. DR MANE-Select; ENST00000315005.8; ENSP00000323663.3; NM_145663.3; NP_663696.1. DR UCSC; uc002ihf.4; human. [Q8NFT6-1] DR AGR; HGNC:17883; -. DR CTD; 80174; -. DR DisGeNET; 80174; -. DR GeneCards; DBF4B; -. DR HGNC; HGNC:17883; DBF4B. DR HPA; ENSG00000161692; Low tissue specificity. DR MIM; 611661; gene. DR neXtProt; NX_Q8NFT6; -. DR OpenTargets; ENSG00000161692; -. DR PharmGKB; PA143485447; -. DR VEuPathDB; HostDB:ENSG00000161692; -. DR eggNOG; KOG4139; Eukaryota. DR GeneTree; ENSGT00530000063909; -. DR HOGENOM; CLU_030726_1_1_1; -. DR InParanoid; Q8NFT6; -. DR OMA; PASCTCQ; -. DR OrthoDB; 5402803at2759; -. DR PhylomeDB; Q8NFT6; -. DR TreeFam; TF332790; -. DR PathwayCommons; Q8NFT6; -. DR SignaLink; Q8NFT6; -. DR BioGRID-ORCS; 80174; 18 hits in 1153 CRISPR screens. DR ChiTaRS; DBF4B; human. DR GenomeRNAi; 80174; -. DR Pharos; Q8NFT6; Tbio. DR PRO; PR:Q8NFT6; -. DR Proteomes; UP000005640; Chromosome 17. DR RNAct; Q8NFT6; Protein. DR Bgee; ENSG00000161692; Expressed in right testis and 114 other cell types or tissues. DR ExpressionAtlas; Q8NFT6; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0031431; C:Dbf4-dependent protein kinase complex; IBA:GO_Central. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0003676; F:nucleic acid binding; IEA:InterPro. DR GO; GO:0030295; F:protein kinase activator activity; IDA:UniProtKB. DR GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB. DR GO; GO:0043539; F:protein serine/threonine kinase activator activity; IBA:GO_Central. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:UniProtKB. DR GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB. DR GO; GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; IMP:UniProtKB. DR GO; GO:1901987; P:regulation of cell cycle phase transition; IBA:GO_Central. DR Gene3D; 6.10.250.3410; DBF zinc finger; 1. DR InterPro; IPR006572; Znf_DBF. DR InterPro; IPR038545; Znf_DBF_sf. DR PANTHER; PTHR15375; ACTIVATOR OF S-PHASE KINASE-RELATED; 1. DR PANTHER; PTHR15375:SF24; PROTEIN DBF4 HOMOLOG B; 1. DR Pfam; PF07535; zf-DBF; 1. DR SMART; SM00586; ZnF_DBF; 1. DR PROSITE; PS51265; ZF_DBF4; 1. DR Genevisible; Q8NFT6; HS. PE 1: Evidence at protein level; KW Alternative splicing; Cell cycle; Metal-binding; Nucleus; Phosphoprotein; KW Reference proteome; Zinc; Zinc-finger. FT CHAIN 1..615 FT /note="Protein DBF4 homolog B" FT /id="PRO_0000317553" FT DOMAIN 43..133 FT /note="BRCT" FT ZN_FING 294..343 FT /note="DBF4-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00600" FT REGION 93..141 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 264..293 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 371..407 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 391..406 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 301 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00600" FT BINDING 304 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00600" FT BINDING 314 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00600" FT BINDING 320 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00600" FT VAR_SEQ 1..186 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_031014" FT VAR_SEQ 157..170 FT /note="GSISGGGSGGSSSL -> VSWGKMGQSRWSPA (in isoform 4)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_031015" FT VAR_SEQ 171..615 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_031016" FT VAR_SEQ 397..615 FT /note="VTQGRAAGQQRWTESLDGVMGPPASHTCVSATTLLPALPKGSREQGCLCPCP FT ASFTQSHLVTSLALLPGEWSPAEDMPLHPSQENSFAPADIPVKGPLLFPEARPWLMSAR FT CWVRPFPFVTWGCLIPHDTTPLHEEVSPCPCLRLGYLYLLLTQSLWCRVRVPSLSTAGP FT IPRTSHPCTLAFPSYLNDHDLGHLCQAKPQGWNTPQPFLHCGFLAVDSG -> GIPEQD FT GTVDSTQAPAERAGTGEVPGPIASCQDLGVSVDVFVDPPGIPVSRSPACQCLLPSSGFM FT ELSSGPDLALFGHKRKVQFPSGSAKKRVGASWPQASFFVPIAPNPCGTRTTSGKRLPSL FT PLTGHESRLLASLQPLCHSQTCLSLPDPFPWQPTDRPAEFWATQPSWLGKGWPPGPEDS FT ECTATGPVSQEAGQLLSCPTAPGWPSAPLYSATSVQPSGAPVESRSTSLLQPLPASAGA FT SCSRCLWAPQPLQVPCLPVSQPWSQPQPQPQPHAGRELLLRVPKVLGSSQGQAAPD FT (in isoform 3)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_031017" FT VAR_SEQ 425..431 FT /note="VSATTLL -> HRPCRLP (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_031018" FT VAR_SEQ 432..615 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_031019" FT CONFLICT 207 FT /note="K -> R (in Ref. 2; AAL75985)" FT /evidence="ECO:0000305" FT CONFLICT 352 FT /note="G -> D (in Ref. 2; AAL75985)" FT /evidence="ECO:0000305" SQ SEQUENCE 615 AA; 67243 MW; 02C1F957B60415A4 CRC64; MSEPGKGDDC LELESSMAES RLRAPDLGVS RCLGKCQKNS PGARKHPFSG KSFYLDLPAG KNLQFLTGAI QQLGGVIEGF LSKEVSYIVS SRREVKAESS GKSHRGCPSP SPSEVRVETS AMVDPKGSHP RPSRKPVDSV PLSRGKELLQ KAIRNQGSIS GGGSGGSSSL LTNARSWGVR ILHVDEMMMH VQQLSLASLC VKKQQPKKPE GTCPAAESRT RKVARLKAPF LKIEDESRKF RPFHHQFKSF PEISFLGPKD ASPFEAPTTL GSMHHTRESK DGEPSPRSAA HTMPRRKKGY CECCQEAFEE LHVHLQSAQH RSFALEAHLY AEVDRIIAQL SHSFADIPFQ AGLPRWSGSP ASDCDPLCPE TLHPHQPSHP RAASPRIRKE DSCQASVTQG RAAGQQRWTE SLDGVMGPPA SHTCVSATTL LPALPKGSRE QGCLCPCPAS FTQSHLVTSL ALLPGEWSPA EDMPLHPSQE NSFAPADIPV KGPLLFPEAR PWLMSARCWV RPFPFVTWGC LIPHDTTPLH EEVSPCPCLR LGYLYLLLTQ SLWCRVRVPS LSTAGPIPRT SHPCTLAFPS YLNDHDLGHL CQAKPQGWNT PQPFLHCGFL AVDSG //